Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 70/100

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Key Takeaway: Artivion, Inc. has announced that it will release its third quarter 2025 financial results on November 6, 2025, after market close. A teleconference will follow at 4:30 p.m. ET, featuring a Q&A session with CEO Pat Mackin. The event will be accessible via phone and webcast, with replays available shortly after.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its financial results, indicating transparency.
  • The teleconference allows for direct engagement with leadership.
  • The company continues to focus on innovative solutions for aortic diseases.

Full Press Release Details

ATLANTA,Oct. 23, 2025/PRNewswire/ --Artivion, Inc. (NYSE:AORT),a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13755945.
The live webcast and replay can be accessed on the Investors section of the Artivion website atwww.artivion.comand by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc.Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website,www.artivion.com.
Contacts:
Artivion
Lance A. Berry
Executive Vice President,
Chief Operating Officer &
Chief Financial Officer
Phone: 770-419-3355
Gilmartin Group LLC
Brian Johnston
Laine Morgan
Phone: 332-895-3222
[email protected]
SOURCE Artivion, Inc.
ArtivionLance A. BerryExecutive Vice President,Chief Operating Officer &Chief Financial OfficerPhone: 770-419-3355 Gilmartin Group LLCBrian JohnstonLaine MorganPhone: 332-895-3222[email protected]

Frequently Asked Questions

When will Artivion release its Q3 2025 financial results?

Artivion will release its Q3 2025 financial results on November 6, 2025.

What time is the teleconference for Q3 2025 results?

The teleconference will take place at 4:30 p.m. ET on November 6, 2025.

How can I access the teleconference replay?

The teleconference replay can be accessed by calling 877-660-6853 or 201-612-7415.

Who will host the Q&A session during the call?

Pat Mackin, the CEO of Artivion, will host the Q&A session.

Where can I find the earnings press release?

The earnings press release will be available in the Investors section of Artivion's website.

Last updated: Oct 23, 2025